U.S. Physical Therapy, Inc. (NYSE:USPH) CEO Christopher J. Reading sold 19,860 shares of the firm’s stock in a transaction on Tuesday, May 21st. The stock was sold at an average price of $119.36, for a total value of $2,370,489.60. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.
Shares of USPH stock traded down $4.89 on Thursday, reaching $115.56. 1,461 shares of the stock were exchanged, compared to its average volume of 108,989. The company has a market cap of $1.53 billion, a P/E ratio of 44.21, a PEG ratio of 3.65 and a beta of 1.15. U.S. Physical Therapy, Inc. has a one year low of $93.00 and a one year high of $129.65. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.39.
U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, May 2nd. The company reported $0.66 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.04. U.S. Physical Therapy had a return on equity of 19.09% and a net margin of 5.34%. The business had revenue of $116.23 million during the quarter, compared to the consensus estimate of $114.12 million. The company’s quarterly revenue was up 7.3% compared to the same quarter last year. As a group, equities research analysts anticipate that U.S. Physical Therapy, Inc. will post 2.92 earnings per share for the current fiscal year.
Hedge funds and other institutional investors have recently modified their holdings of the stock. TCG Advisors LP acquired a new position in U.S. Physical Therapy during the first quarter valued at approximately $25,000. Resources Investment Advisors Inc. bought a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $42,000. Vestor Capital LLC bought a new position in shares of U.S. Physical Therapy during the fourth quarter worth approximately $51,000. Quadrant Capital Group LLC increased its stake in shares of U.S. Physical Therapy by 1,729.4% during the first quarter. Quadrant Capital Group LLC now owns 622 shares of the company’s stock worth $63,000 after purchasing an additional 588 shares during the period. Finally, Cresset Asset Management LLC bought a new position in U.S. Physical Therapy during the 1st quarter worth $76,000. 99.58% of the stock is owned by hedge funds and other institutional investors.
A number of research analysts have recently commented on the company. Zacks Investment Research lowered U.S. Physical Therapy from a “buy” rating to a “hold” rating in a report on Saturday, February 9th. ValuEngine lowered U.S. Physical Therapy from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, March 6th. William Blair started coverage on U.S. Physical Therapy in a research report on Thursday, March 7th. They set an “outperform” rating and a $106.61 price objective for the company. TheStreet raised U.S. Physical Therapy from a “c+” rating to a “b” rating in a research note on Friday, March 8th. Finally, Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a research note on Friday, May 3rd. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $111.40.
TRADEMARK VIOLATION NOTICE: “Insider Selling: U.S. Physical Therapy, Inc. (USPH) CEO Sells 19,860 Shares of Stock” was published by Community Financial News and is the property of of Community Financial News. If you are reading this piece on another domain, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The legal version of this piece can be read at https://www.com-unik.info/2019/05/23/insider-selling-u-s-physical-therapy-inc-usph-ceo-sells-19860-shares-of-stock.html.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
See Also: Cost of Capital
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.